Objective: To understand the barriers or factors that may hinder receipt of the Human Papilloma virus (HPV) among adolescent girls 14-18 years old, and evaluate the awareness level about HPV and the HPV vaccine acceptance.
INTRODUCTION
Cervical cancer is a major public health problem in the developing world, including Latin America and the Caribbean (LAC) (1, 2, 3) , and the second most common cancer (after breast cancer) among women in LAC. Cervical cancer affects relatively young women while still involved in their careers, and caring for family; resulting in more lives lost than many other cancers. The LAC region accounts for 14.6% of the worldwide cervical cancer cases, and 11.95% of cervical cancer deaths (4) . Recent estimates indicate that if current incidence rates continue, and current screening efforts kept at present levels of effectiveness, by 2025 developing countries will face an increase of 75% in the burden of cervical cancer (1, 5) .
Cervical cancer rates in Latin America and the Caribbean countries are high compared to other regions of the world except Africa (3).
Pap smear screening was introduced in LAC in the 1960's and although attempts to implement national programs have been pursued, the successful reduction of cervical cancer incidence and mortality that has been achieved in other developed countries has not been replicated in LAC (3) . Failure to reduce the burden of cervical cancer, may be due to socioeconomic factors, lack of organized screening, limitations of techniques, poor quality control, low population coverage, insufficient monitoring, treatment and follow-up of women with abnormal cytology results (5).
The cervical cancer incidence rate in Trinidad and Tobago is about two times higher than the worldwide rate (6) . Trinidad and Tobago ranks number 18 in the region with an age standardized incidence rate of 27.1 per 100,000, when compared to Puerto Rico with a rate of 8.8 per 100,000 (1) . Mortality rates are much higher in Caribbean including Trinidad and Tobago (10.7 per 100,000) than in North America which has a rate of 2.3 per 100,000 (1) .
With the advent of screening programs, the incidence of abnormal cervical cytology has been rising among women of reproductive age, and conservative methods to treat cervical intraepithelial neoplasia (CIN) and microinvasive cervical cancers are often used on young women. The incidence of CIN requiring treatment tends to peak around the age of 30, and the possible effect on future childbearing is of great importance (7) . Recent research on conization (tissue excision) to treat (CIN) has been linked to the risk of preterm births. While it is still controversial, conization of the cervix for treatment of CIN is known to be related to adverse pregnancy outcomes including preterm delivery, low birth weight infants, incompetent cervix, and cervical stenosis (8, 9) . It is expected that the HPV vaccine would reduce the need for conization therefore improving perinatal mortality and other adverse pregnancy outcomes in the long term.
HPV vaccination may reduce cervical cancer burden through primary prevention of HPV infection. Two brands of HPV vaccines are available, a bivalent (Ceravix) and a quadrivalent vaccine that is also effective against non-oncogenic types HPV 16 and11 which cause most genital warts (10) . HPV infections are usually acquired soon after sexual debut; therefore the vaccine is most effective if administered before onset of sexual activity. Either HPV vaccine is routinely recommended for 11-12 year old girls, and 13-26 year old females (10) .
Surveys conducted across the region have shown median age at first sexual intercourse to be in the early to mid-teens, or in the case of some studies with boys, at even younger ages. Data from the largest English speaking Caribbean Youth Health Survey, conducted among 15,695 youths aged 10-18 attending school, in nine countries, revealed 34% responded in the affirmative to ever having sexual intercourse. Over half of the sexually active boys, and a quarter of the sexually active girls said that age at first intercourse was ten years old or younger (11) .
Additionally, the first sexual intercourse of 47.6% girls and 31.9% of boys who were sexually active, was forced or coerced (12) . The Pan American Health Organization adolescent survey revealed that 38% of young people said their first intercourse was forced. In Tobago, 7% of first sexual encounters by males and 6% of those by females were reported to be incestuous (13) .
These victims usually have little choice over whether birth control would be used during the encounter and they may often contract a sexually transmitted infection (STI). Reports of other risky sexual behaviors include young females being sexually initiated by significantly older males (13, 14) ; and transactional sex with older men for school fees, money, and clothing (12) .
Research conducted in the United States to determine adolescent's understanding and acceptance of the HPV vaccine found that only 4% of adolescents in the study believed that they were at risk for HPV infection, but 52% were willing to be vaccinated. There was a general lack of awareness of HPV among the students in the study. Yet HPV is the most common sexually transmitted virus in the United States with at least 50% of all sexually active people having acquired it in their lifetime (15) . Because of the high incidence of cervical cancer in the LAC region, including Trinidad and Tobago, we saw a need for similar investigations into the knowledge, understanding, and acceptance of the HPV vaccine in relation to cervical cancer in Trinidad and Tobago. To the best of our knowledge, no other study has specifically investigated these variables among adolescents in the region.
METHODS
Recruitment for this study was done through secondary schools in Trinidad and Tobago. The principals of the selected schools were contacted and the purpose of the study explained.
Information on the purpose of the study and consent forms were sent to the parents by the teachers. Female adolescents meeting the age criteria (14-18 years), and who had returned their signed consent forms were invited to participate. Schools were only included if the principals agreed for their school to participate.
Data Collection
The sample goal was 1300 surveys, and approximately 1600 consent forms were sent to parents; but only 651 female adolescents participated. Surveys were administered to approximately 16 schools during a class period by the researchers, or other assigned personnel. Data collection lasted for 4.5 months from mid-March until June, 2014. The questionnaire consisted of two parts; the first section elicited the adolescent's demographic information, including parents' education, and family history. The second section was broken into clusters of questions on knowledge, beliefs, and attitudes about cervical cancer, the HPV vaccine, and the spread of the HPV virus. Two questions were included on intention or how willing they were to accept the vaccine in the future. Some questions elicited responses by using Likert type scales, for example a scale of 1-5 (1= strongly disagree to 5= strongly agree); while others were, yes, no, responses.
The question on willingness to accept the vaccine was measured on a scale of 1-10. Participants took 10-15 minutes to complete the questionnaire. Every effort was made to ensure that students did not identify themselves on the questionnaire. Any identifying information de-identified prior to data entry.
Data Analysis
Data was entered into the Statistical Packages for the Social Sciences (SPSS) version 20. The data was cleaned and descriptive statistics were run on demographics and all categorical information. Statistical Analysis System (SAS) version 9.4 was also used to conduct logistic regression analyses on several variables for associations. Statistical tests used throughout the analysis to examine the majority of associations relevant to the questions were Chi-Square and Kendal Tau; Binary logistic regression when the outcome (dependent variable) was nominal and dichotomous; Multinomial logistic regression when the nominal outcome had more than two levels, and ordinal logistic regression when the outcome was ordinal. Table 1 outlines the students' demographic characteristics. There was a total of 651 female students ages 14-18. Of these, the majority (61%) were 15-16 years old, 76% were of African descent or multi-racial. In terms of religion, most (71%) were Christians, with Pentecostals, SDAs, and Catholics being the highest denominations. The data showed that 48% of mothers and fathers completed high school, while 25% of mothers and 22% of fathers completed college.
RESULTS
Participants were asked where they generally go for health care and were given a list of facilities, from which to select more than one; 42% checked doctor's office, 29% checked community center. Only 8% indicated that they did not get health care. There was no association between demographics and type of health care facility attended, but the 15-16 year olds were more likely to go to a doctor's office for healthcare. They were also asked if they see a pediatrician, and the majority (50%) said no. Eighty-three percent had never seen a gynecologist.
Logistic regression analysis showed a significant difference between Hindu and
Pentecostal religions in the odds of being willing to accept the vaccination (OR 0.469; 95% CI [0.257, 0.855]), with Hindus being 53% less willing to be vaccinated for HPV. The 15 and 16 year olds (32%) and (30%) respectively, showed more willingness to accept the vaccine than any other age group; 45% of African descent, and 33% multi-racial students were more willing to accept the vaccine. It was also noted, though not significantly, that girls whose parents had a high school education were more willing to accept the HPV vaccine. In examining knowledge questions using Chi-Square test, only age was associated with having heard of Pap screening.
Girls 15 and 16 years old were more likely to say yes that they heard of pap testing for cervical cancer.
There was a significant association between a family member having a diagnosis of cervical cancer and knowledge that cervical cancer is caused by the HPV virus, that HPV virus is spread sexually, and that there was a likelihood of getting cervical cancer in the future, or in the next few years, p < .05. However, there was no significant association between family diagnosis of cervical cancer and knowledge that a Pap test can help find cancer in its early stages of development.
The impact of family history was assessed in reference to knowledge of cervical cancer and HPV. When asked if anyone in their family was diagnosed with cervical cancer, 50% said no, but 40% were unsure; only 10% had a family member diagnosed with cervical cancer. A little over 53% had heard about the HPV vaccine, and 70% heard about the HPV vaccine, 94% also heard about STIs, but the majority (58%) never heard of the Pap test, and an overwhelming 72% did not know why women received Pap screening. As to whether an older or younger sibling had received the vaccine, 69%, and 78% said no for older and younger siblings respectively. They were asked if they had received the HPV vaccine and the majority (80%) said no; only 8% indicated that they had received the HPV vaccine, and of these, only 50% knew that the virus was spread through sexual contact. Chi-Square tests showed significant evidence (p<.05) of an association between those with an older sibling who had the HPV vaccine and knowledge that cervical cancer is caused by the HPV virus.
The knowledge questions were recoded to strongly agree or agree, strongly disagree or disagree, and no opinion, since a large number seemed to have no opinion. Table 2 presents HPV and Cervical Cancer knowledge, showing more incorrect answers. The majority (63%) did not know that cervical cancer is caused by the HPV virus; 56% did not know that the HPV virus is spread sexually. However, when adjusting for age, the 17 and 18 year olds were more knowledgeable when compared to 14, 15, and 16 year olds.
In terms of beliefs about cervical cancer and HPV virus, 56% believed that it was very or moderately possible to reduce their risks of developing cervical cancer, 25% believed it was a little possible and 18% believed that it was not possible. Participants were asked if their doctor ever told them that they should get the HPV vaccine, and 77% said no. They were to indicate if they believed the HPV vaccine would make them sick, and most (53%) were unsure if the vaccine would get them sick. However, but 16% believed that the vaccine will get them sick; 46% said they would take the vaccine if it were offered to them; 35% were unsure, but 19% said they would refuse taking the vaccine.
DISCUSSION
This is the first study to our knowledge that has explored the barriers to the HPV vaccine in Trinidad and Tobago and the knowledge of adolescents about the HPV virus. Previous research has shown that a physician's recommendation is a significant factor in the receipt of the vaccine (16) . Consequently, providers may be a major cause of the low vaccination rate (17) . In addition, many girls this age do not routinely see pediatricians as this is not a common practice in Trinidad and Tobago and they may be too young to begin seeing a gynecologist.
Religion has a major influence on the culture of Trinidad and Tobago and most of LAC. (18) . Recommending the vaccine to prevent cervical cancer may be more appealing (17, 19) . In our study, several of the religious-based schools did not allow the survey to be conducted in their schools. The major religious groups who participated in the study were Pentecostals, Seventh-day Adventists and Catholics.
Nontraditional settings such as churches have been used to increase vaccination against influenza in the United States (20) . While churches would willingly engage in many health promotion campaigns it is unclear whether Caribbean churches would readily promote a vaccine that is designed to prevent the spread of an STI that may lead to cancer. This can be explored in future vaccination campaigns. Theatrical health education can be used as a mechanism to educate adolescents about the vaccine and its spread. Limitations of the study include a small sample and the lack of generalizability to other populations.
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